Study indicates interleukin-6-dependant pathway dysregulatio

Study indicates interleukin-6-dependant pathway dysregulation as a key druggable feature of COVID-19

Researchers identified an interleukin 6 dependent alternative pathway as a therapeutic strategy against coronavirus disease 2019.

Related Keywords

, Marynaolyak Shutterstock , Complement Atlas , Discovery Industry Focus , Coronavirus Disease Covid 19 , Covid 19 , Nterleukin , Interleukin 6 , Coronavirus , Immune System , Inase , Phagocytosis , Protein , Espiratory , Cars , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome , Virus ,